Atlas Trials

High-dose Pemetrexed to Treat Lung Adenocarcinoma With Brain Metastases

Clinical trial NCT02284490 · UNKNOWN

Trial details

NCT number
NCT02284490
Sponsor
Rongjie Tao
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Brain Metastases
Start date
2014-11-01
Primary completion
2016-10-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.